WHO prequalifies VISITECT® CD4 Advanced Disease
VISITECT® CD4 Advanced Disease supports the identification of advanced disease in people living with HIV. VISITECT® CD4 Advanced Disease is a unique, instrument-free, rapid and disposable CD4 test benefiting patients and healthcare providers.
Contact us for more information
We are meeting the demand for both point-of-care and laboratory-based tests for COVID-19 diagnostics
Focus on unique VISITECT® CD4 rapid tests enabling access to people living with HIV in low- and middle-income countries
Point-of-care and laboratory-based solutions for food intolerance and gut health
Omega announces that following completion of the of US performance studies, its technology partner, Mologic Ltd has filed its submission to the U.S. Food...
Depending on the status of the global pandemic and travel restrictions, Omega hopes to exhibit at the following exhibitions this year:
Medica, 15-18 November 2021